切换至 "中华医学电子期刊资源库"

中华普外科手术学杂志(电子版) ›› 2025, Vol. 19 ›› Issue (03) : 262 -265. doi: 10.3877/cma.j.issn.1674-3946.2025.03.009.

论著

基于膜解剖的完整系膜切除+D2根治术在进展期胃癌治疗中的应用
李华志1, 孙海涛2, 曹广1,(), 张雅静1   
  1. 1. 100029 北京,首都医科大学附属北京安贞医院普外科
    2. 101199 北京,首都医科大学附属北京潞河医院普外科
  • 收稿日期:2024-05-14 出版日期:2025-06-26
  • 通信作者: 曹广
  • 基金资助:
    北京市通州区科技计划项目(KJ2024CX039)北京市自然科学基金(L182048)

Application of complete mesocolic excision based on membrane anatomy + D2 radical resection in the treatment of advanced gastric cancer

Huazhi Li1, Haitao Sun2, Guang Cao1,(), Yajing Zhang1   

  1. 1. Department of General Surgery,Beijing Anzhen Hospital,Capital Medical University,Beijing 100029,China
    2. Department of General Surgery,Beijing Luhe Hospital Affiliated to Capital Medical University,Beijing 101199,China
  • Received:2024-05-14 Published:2025-06-26
  • Corresponding author: Guang Cao
引用本文:

李华志, 孙海涛, 曹广, 张雅静. 基于膜解剖的完整系膜切除+D2根治术在进展期胃癌治疗中的应用[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(03): 262-265.

Huazhi Li, Haitao Sun, Guang Cao, Yajing Zhang. Application of complete mesocolic excision based on membrane anatomy + D2 radical resection in the treatment of advanced gastric cancer[J/OL]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2025, 19(03): 262-265.

目的

探讨基于膜解剖的完整系膜切除+D2根治术在进展期胃癌治疗中的应用效果。

方法

回顾性分析2020年6月至2023年2月175例进展期胃癌患者病例资料,依据术式不同分为对照组(单纯接受D2根治性手术,n=86例)和观察组(接受基于膜解剖的完整系膜切除+D2根治术,n=89例)。使用统计学软件SPSS 25.0处理数据,围手术期指标、胃肠功能指标等计量资料以(±s)表示,采用独立样本t检验;术后并发症等计数资料用[例(%)]表示,行χ2检验;采用Kaplan-Meier统计进展期胃癌复发风险函数。P<0.05为差异有统计学意义。

结果

观察组患者术中出血量较对照组少,术中淋巴结清扫数量较对照组多,术后肠鸣音恢复时间较对照组短(P<0.05);术后7d,两组患者胃动素、胃泌素水平上升,且观察组高于对照组,二胺氧化酶(DAO)水平下降,且观察组较对照组低(P<0.05);两组患者术后并发症发生率差异无统计学意义(P>0.05);术后12个月,观察组患者复发率低于对照组(6.7% vs.16.3%,P=0.047);观察组患者复发中位时间7.5(5.8,9.5)个月低于对照组6.5(5.0,9.3)个月(P=0.046)。

结论

将基于膜解剖的完整系膜切除+D2根治术应用于进展期胃癌患者中,术中出血量降低,淋巴结清扫数量提升,患者术后胃肠功能恢复快,且可降低胃癌复发风险,应用效果好。

Objective

To explore the application effect of complete mesocolic excision based on membrane anatomy+D2 radical resection in the treatment of advanced gastric cancer.

Methods

The case data of 175 patients with advanced gastric cancer from June 2020 to February 2023 were retrospectively analyzed.According to different surgical procedures,they were divided into the control group (receiving only D2 radical surgery,n=86 cases) and the observation group (receiving complete mesocolic excision based on membrane anatomy+D2 radical resection,n=89 cases).The statistical software SPSS 25.0 was used for data processing.Perioperative indexes and gastrointestinal function were expressed as (±s),and independent sample t test was used between groups; Count data such as postoperative complications were expressed as[ cases(%)],and χ2 test was performed; The Kaplan-Meier method was used to statistically analyze the recurrence risk function of advanced gastric cancer.A P value<0.05 was considered statistically significant.

Results

The intraoperative blood loss of patients in the observation group was less than that in the control group,the number of lymph node dissections during the operation was more than that in the control group,and the recovery time of bowel sounds after the operation was shorter than that in the control group (P<0.05).Seven days after the operation,the levels of motilin and gastrin in both groups increased,and those in the observation group were higher than those in the control group.The level of diamine oxidase (DAO) decreased,and that in the observation group was lower than that in the control group (P<0.05).There was no significant difference in the incidence of postoperative complications between the two groups (P>0.05).Twelve months after the operation,the recurrence rate of patients in the observation group was lower than that in the control group (6.7% vs.16.3%,P=0.047).The median recurrence time of patients in the observation group was 7.5 (5.8,9.5) months,which was lower than 6.5 (5.0,9.3) months in the control group (P=0.046).

Conclusion

Applying complete mesocolic excision based on membrane anatomy + D2 radical resection to patients with advanced gastric cancer can reduce intraoperative blood loss,increase the number of lymph node dissections,accelerate the recovery of gastrointestinal function after the operation,and reduce the recurrence risk of gastric cancer,with a good application effect.

表1 两组进展期胃癌患者一般资料比较
表2 两组进展期胃癌患者围手术期指标对比(±s
表3 两组进展期胃癌患者胃肠功能比较(±s
表4 两组进展期胃癌患者术后并发症比较[例(%)]
[1]
牛福勇,韩永军.3D腹腔镜近端胃癌根治术在直径>5cm的T3-4期胃癌患者中的应用研究[J/CD].中华普外科手术学杂志(电子版),2021,15(06): 657-660.
[2]
徐超,周厚民,王云强,等.开腹与腹腔镜远端胃癌D2根治术治疗进展期胃癌的效果及对患者免疫功能和应激反应的影响[J].湖南师范大学学报(医学版),2021,18(04): 93-96.
[3]
解亦斌,邵欣欣,丁世康,等.重视精准医学时代下胃系膜外科学的研究[J].中华医学杂志,2022,102(12): 827-829.
[4]
肖海鹏,陆艳军,钟新强,等.腹腔镜胃癌根治术中胃右系膜完整切除的体会[J].腹腔镜外科杂志,2024,29(1):32-59.
[5]
刘洋,李有国,张洪义.从膜解剖浅谈腹腔镜直肠癌全系膜切除的新认识[J].中国临床医生杂志,2021,49(4):397-398.
[6]
牛敏娟,厉琳杰,郗欢,等.从胚胎学与膜解剖理解完整结肠系膜切除手术[J].结直肠肛门外科,2021,27(03): 188-196.
[7]
邓少博,许长录,阎海.手套通路经肛全直肠系膜切除术与传统术式在直肠癌根治术中的应用效果及对患者术后排便功能的影响[J].中国内镜杂志,2022,28(06): 33-40.
[8]
喻晨,王伟,付广,等.膜解剖完整系膜切除理念在直肠癌根治术中的临床疗效评价[J].肿瘤防治研究,2023,50(08): 777-781.
[9]
葛均波,徐永健,王辰.内科学[M].第9版.北京:人民卫生出版社,2018: 364-367.
[10]
中国腹腔镜胃肠外科研究组(CLASS)中国抗癌协会胃癌专业委员会,中华医学会外科分会腹腔镜与内镜外科学组.腹腔镜局部进展期远端胃癌D2根治术标准操作流程:研究共识[J].中华胃肠外科杂志,2019,22(09): 807-811.
[11]
Faiz Z,Hayashi T,Yoshikawa T.Lymph node dissection for gastric cancer:Establishment of D2 and the current position of splenectomy in Europe and Japan[J].Eur J Surg Oncol,2021,47(9): 2233-2236.
[12]
蒋晓,张龙,尤玉成,等.基于D2淋巴结清扫的两种术式治疗胃癌的近中期随访评价[J/CD].中华普外科手术学杂志(电子版),2021,15(06): 650-652.
[13]
Chittawadagi B,Nayak SK,Ramakrishnan P,et al.Laparoscopic D2 gastrectomy in advanced gastric cancer:Postoperative outcomes and long-term survival analysis[J].Asian J Endosc Surg,2021,14(4): 707-716.
[14]
付海啸,李腾腾,王凯,等.膜解剖理念在达芬奇机器人辅助直肠癌TME中的应用[J].结直肠肛门外科,2023,29(01): 14-18.
[15]
郭震,朱淑娟,张宜,等.男性直肠前间隙解剖学研究及其在经肛全直肠系膜切除临床应用[J].中国实用外科杂志,2022,42(07): 806-809,817.
[16]
张明凯,穆东,陈艳,等.腹腔镜D2根治术联合胃背侧系膜近胃端完整系膜切除术治疗进展期胃癌的近期疗效[J].中国现代医学杂志,2021,31(14): 30-34.
[17]
汤忠祝,刘冬,吴列,等.局部进展期胃癌D2根治术R0切除患者术后放化疗与术后化疗长期生存和复发对比: 10年随访回顾性分析[J].肿瘤学杂志,2023,29(06): 489-494.
[18]
莫波,王佩,童宜欣,等.膜解剖技术在胃癌根治术中应用的效果分析[J].临床外科杂志,2022,30(09): 835-838.
[19]
刘惠滨,邱仙土,郑长悦,等.基于膜解剖的胃后间隙入路在全腹腔镜近端胃切除双通道吻合术中的应用[J].中国微创外科杂志,2023,23(09): 709-714.
[20]
张秀真,张岩,牛卫丽.基于D2胃切除术的系统性胃系膜切除术对进展期胃癌患者的疗效分析[J].实用癌症杂志,2023,38(09): 1494-1497.
[21]
白明瀚,孙凌宇,郑宏群,等.基于膜解剖理论的全直肠系膜切除层面显露与筋膜辨识[J].中国实用外科杂志,2023,43(10): 1188-1195.
[1] 王占奎, 陈治远, 孙闻晖, 杨庆玲, 杨小斌. 术前免疫炎症指数及AFU水平对肝癌患者介入术后早期复发的预测研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(03): 247-250.
[2] 吉林霞, 范小春, 梁琴. 胃癌常见术后并发症类型及危险因素研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(02): 220-223.
[3] 姚宏伟, 孙丽婷, 吴偲, 舒文龙, 高加勒, 杨正阳, 吴国聪, 张忠涛. 新辅助放化疗联合免疫治疗局部进展期直肠癌的探索与实践[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(02): 123-127.
[4] 王乾宇, 杜峻峰, 李世拥. 新辅助放化疗联合免疫治疗局部进展期直肠癌的突破与挑战[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(02): 128-131.
[5] 韦洋, 赵远权, 王小波, 黄海, 陈洁. BCLC 0/A期肝细胞癌患者术后辅助治疗后早期复发风险分析及预测模型建立[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(02): 157-161.
[6] 艾世超, 孙艺文, 宋鹏, 沈晓菲, 刘颂, 孙锋, 陆晓峰, 王萌, 管文贤. 静脉注射吲哚菁绿导航胃癌根治术的单臂开放前瞻性研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(02): 166-169.
[7] 李贞贞, 王宏刚, 崔丽丽, 缪月琴, 刘万璐. 改良管状胃—食管吻合术在腹腔镜近端胃切除消化道重建中的安全性及抗反流效果研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(02): 176-179.
[8] 邓崇文, 廖喜望, 施幼雄, 龚俊, 钟洪. 腹腔镜下胃癌D2根治+腹主动脉旁淋巴结清扫术治疗局部进展期胃癌的临床研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(02): 180-183.
[9] 薛林强, 戈军刚, 高林, 钱雷敏, 黄建明. 改良SPLT食管-空肠吻合术在腹腔镜全胃切除术中的应用[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(02): 212-215.
[10] 李国新, 陈新华. 全腹腔镜下全胃切除术食管空肠吻合的临床研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 1-4.
[11] 陈方鹏, 杨大伟, 金从稳. 腹腔镜近端胃癌切除术联合改良食管胃吻合术重建His角对术后反流性食管炎的效果研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 15-18.
[12] 许杰, 李亚俊, 韩军伟. 两种入路下腹腔镜根治性全胃切除术治疗超重胃癌的效果比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 19-22.
[13] 李永红, 王骏, 肖恒军. 2025-NCCN前列腺癌诊治指南更新解读[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(02): 129-133.
[14] 汪朕红, 周健, 陈国彪, 宋红华, 高振国, 覃相志, 雷希延, 龚磊, 吕真冰, 田云鸿. 胃癌术中联合胃镜空气亚甲蓝测漏技术的有效性和安全性研究[J/OL]. 中华腔镜外科杂志(电子版), 2025, 18(01): 25-31.
[15] 颜军, 郭诗翔, 吴堃. 新辅助治疗后“二步法”改良Appleby 术治疗局部进展期胰体癌[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(02): 274-280.
阅读次数
全文


摘要